Diffuse large B cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency. Other risk factor include Epstein-Barr virus. | |||
==Risk factors== | ==Risk factors== | ||
Line 12: | Line 12: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] |
Revision as of 15:34, 21 August 2015
Diffuse large B cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diffuse large B cell lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Diffuse large B cell lymphoma risk factors |
Directions to Hospitals Treating Diffuse large B cell lymphoma |
Risk calculators and risk factors for Diffuse large B cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency. Other risk factor include Epstein-Barr virus.
Risk factors
- An underlying immunodeficiency is a significant risk factor.
- Infection with Epstein-Barr virus has also been found to contribute to the development of some subgroups of Diffuse large B cell lymphoma.